These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 20488484)

  • 1. Total endoscopic and anal irrigation management approach to noncompliant neuropathic bladder in children: a good alternative.
    Neel KF
    J Urol; 2010 Jul; 184(1):315-8. PubMed ID: 20488484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total endoscopic management (TEM approach) of children with non-compliant neuropathic bladder: a preliminary report.
    Neel KF; Salem M; Soliman S
    J Pediatr Urol; 2008 Apr; 4(2):124-6. PubMed ID: 18631907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical injection of botulinum toxin type A: management of neuropathic bladder and bowel dysfunction in children with myelomeningocele.
    Kajbafzadeh AM; Moosavi S; Tajik P; Arshadi H; Payabvash S; Salmasi AH; Akbari HR; Nejat F
    Urology; 2006 Nov; 68(5):1091-6; discussion 1096-7. PubMed ID: 17113899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postpubertal urodynamic and upper urinary tract changes in children with conservatively treated myelomeningocele.
    Almodhen F; Capolicchio JP; Jednak R; El Sherbiny M
    J Urol; 2007 Oct; 178(4 Pt 1):1479-82. PubMed ID: 17706702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Minimally invasive, safe treatment of the neurogenic bladder with botulinum-A-toxin in children with myelomeningocele].
    Lusuardi L; Nader A; Koen M; Schrey A; Schindler M; Riccabona M
    Aktuelle Urol; 2004 Feb; 35(1):49-53. PubMed ID: 14997415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total endoscopic and anal irrigation management approach to noncompliant neuropathic bladder and bowel in children: A long-term follow-up.
    Alqarni N; Alhazmi H; Alsowayan O; Eweda T; Neel KF
    Urol Ann; 2017; 9(4):362-365. PubMed ID: 29118540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trigonal injection of botulinum toxin-A does not cause vesicoureteral reflux in neurogenic patients.
    Mascarenhas F; Cocuzza M; Gomes CM; Leão N
    Neurourol Urodyn; 2008; 27(4):311-4. PubMed ID: 17914742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant repeated intravesical injections of botulinum toxin-type A and laparoscopic antegrade continence enema; a new solution for an old problem.
    Kajbafzadeh A; Mahboubi AH; Payabvash S
    BJU Int; 2009 May; 103(9):1248-54. PubMed ID: 19154454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing concepts concerning the management of vesicoureteral reflux.
    Herndon CD; DeCambre M; McKenna PH
    J Urol; 2001 Oct; 166(4):1439-43. PubMed ID: 11547107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravesical injections of botulinum toxin type A for management of neuropathic bladder: a comparison of two methods.
    Safari S; Jamali S; Habibollahi P; Arshadi H; Nejat F; Kajbafzadeh AM
    Urology; 2010 Jul; 76(1):225-30. PubMed ID: 20110117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type A for neurogenic detrusor overactivity due to spinal cord lesions in children: a retrospective study of seven cases.
    Do Ngoc Thanh C; Audry G; Forin V
    J Pediatr Urol; 2009 Dec; 5(6):430-6. PubMed ID: 19577520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.
    Giannantoni A; Mearini E; Del Zingaro M; Porena M
    Eur Urol; 2009 Mar; 55(3):705-11. PubMed ID: 18814955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum A toxin urethral sphincter injection in children with nonneurogenic neurogenic bladder.
    Mokhless I; Gaafar S; Fouda K; Shafik M; Assem A
    J Urol; 2006 Oct; 176(4 Pt 2):1767-70; discussion 1770. PubMed ID: 16945643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder dynamics and vesicoureteral reflux: factors associated with idiopathic lower urinary tract dysfunction in children.
    Ural Z; Ulman I; Avanoglu A
    J Urol; 2008 Apr; 179(4):1564-7. PubMed ID: 18295262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type a injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux.
    Karsenty G; Elzayat E; Delapparent T; St-Denis B; Lemieux MC; Corcos J
    J Urol; 2007 Mar; 177(3):1011-4. PubMed ID: 17296399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy of subureteral collagen injection for endoscopic treatment of vesicoureteral reflux in neurogenic bladder cases.
    Haferkamp A; Möhring K; Staehler G; Gerner HJ; Dörsam J
    J Urol; 2000 Jan; 163(1):274-7. PubMed ID: 10604375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endoscopic treatment of vesico-ureteral reflux in the neurogenic bladder. Presentation of 2 cases and review of the literature].
    Casals Armada J; Rivero Alviza A; Rivero Ojeda J
    Arch Esp Urol; 1997 May; 50(4):381-7. PubMed ID: 9313047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type A injections for treating neurogenic detrusor overactivity combined with low-compliance bladder in patients with spinal cord lesions.
    Klaphajone J; Kitisomprayoonkul W; Sriplakit S
    Arch Phys Med Rehabil; 2005 Nov; 86(11):2114-8. PubMed ID: 16271557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of botulinum toxin A injection for the management of external sphincter dyssynergia in neurologically normal children.
    Franco I; Landau-Dyer L; Isom-Batz G; Collett T; Reda EF
    J Urol; 2007 Oct; 178(4 Pt 2):1775-9; discussion 1779-80. PubMed ID: 17707430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
    Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB
    Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.